SCHEMBL23112283

SCHEMBL23112283

CCOC(=O)c1nn(CC(=O)c2cc(F)c(Cl)c(F)c2)c(C(=O)OCC)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
POLB P06746 1/20 0.38
RAB9A P51151 4/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 2/20 0.37
ELANE P08246 2/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
NPC1 O15118 2/20 0.36
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28546862 0.85 TSHR (0.51) ALDH1A1TSHRRAB9ATP53ELANE
SCHEMBL23112450 0.85 TSHR (0.37) ALDH1A1TSHRPOLBRAB9AGAA
SCHEMBL23112632 0.81 RAB9A (0.43) ALDH1A1TSHRRAB9AGAAELANE
SCHEMBL29977898 0.81 RAB9A (0.43) ALDH1A1TSHRRAB9AGAAELANE
SCHEMBL28556281 0.76 ALDH1A1 (0.41) ALDH1A1TSHRRAB9AGAATP53
SCHEMBL28545438 0.76 KDM4E (0.49) ALDH1A1TSHRRAB9AELANENPSR1
SCHEMBL28554167 0.76 ALDH1A1 (0.41) ALDH1A1TSHRRAB9AGAATP53
SCHEMBL23112723 0.76 PDE4A (0.39) ALDH1A1TSHRRAB9AGAATP53
SCHEMBL23112344 0.76 PDE4A (0.39) ALDH1A1TSHRRAB9AGAATP53
SCHEMBL23112673 0.76 PDE4A (0.39) ALDH1A1TSHRRAB9AGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-10-13 US disclosed
EP-3793559-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-03-24 EP disclosed
CN-112469412-A Substituted dihydropyrazolopyrazine carboxamide derivatives 拜耳公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES QDPR, SIRT5, PDXK ALDH1A1 767/4885TSHR 3722/4885POLB 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.